A cellular star atlas: using astrocytes from human pluripotent stem cells for disease studies

What roles do astrocytes play in human disease?This question remains unanswered for nearly every human neurological disorder. Yet, because of their abundance and complexity astrocytes can impact neurological function in many ways. The differentiation of human pluripotent stem cells (hPSCs) into neur...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in cellular neuroscience Vol. 7; p. 25
Main Authors Krencik, Robert, Ullian, Erik M.
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Research Foundation 14.03.2013
Frontiers Media S.A
Subjects
Online AccessGet full text
ISSN1662-5102
1662-5102
DOI10.3389/fncel.2013.00025

Cover

More Information
Summary:What roles do astrocytes play in human disease?This question remains unanswered for nearly every human neurological disorder. Yet, because of their abundance and complexity astrocytes can impact neurological function in many ways. The differentiation of human pluripotent stem cells (hPSCs) into neuronal and glial subtypes, including astrocytes, is becoming routine, thus their use as tools for modeling neurodevelopment and disease will provide one important approach to answer this question. When designing experiments, careful consideration must be given to choosing paradigms for differentiation, maturation, and functional analysis of these temporally asynchronous cellular populations in culture. In the case of astrocytes, they display heterogeneous characteristics depending upon species of origin, brain region, developmental stage, environmental factors, and disease states, all of which may render experimental results highly variable. In this review, challenges and future directions are discussed for using hPSC-derived astroglial progenitors and mature astrocytes for neurodevelopmental studies with a focus on exploring human astrocyte effects upon neuronal function. As new technologies emerge to measure the functions of astrocytes in vitro and in vivo, there is also a need for a standardized source of human astrocytes that are most relevant to the diseases of interest.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Edited by: Keith Murai, McGill University, Canada
Reviewed by: Carole Escartin, MIRCen, France; Keith Murai, McGill University, Canada; Ben Barres, Stanford University, USA
ISSN:1662-5102
1662-5102
DOI:10.3389/fncel.2013.00025